VACCINEX, INC. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

VACCINEX, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $601.0 thousand for the year ending 2024.

  • VACCINEX, INC. showed an increase of +5.4% in Revenue From Contract With Customer Excluding Assessed Tax from 2023 to 2024.
  • This data is from VACCINEX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
  • XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2017 to 2024), VACCINEX, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 567.8%.
  • Historical annual values: Fiscal year 2024: $601.0 thousand | Fiscal year 2023: $570.0 thousand | Fiscal year 2022: $275.0 thousand | Fiscal year 2021: $900.0 thousand | Fiscal year 2020: $625.0 thousand | Fiscal year 2019: $523.0 thousand | Fiscal year 2018: $724.0 thousand | Fiscal year 2017: $90.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: